References
Akhtar S. (2006). Non-viral cancer gene therapy: beyond delivery.Gene Therapy , 13 , 739-740.
Chiu Y.-L., Ali A., Chu C.-y., Cao H., & Rana T. M. (2004). Visualizing
a Correlation between siRNA Localization, Cellular Uptake, and RNAi in
Living Cells. Chemistry & Biology , 11 , 1165-1175.
Deng Y., Wang C. C., Choy K. W., Du Q., Chen J., Wang Q., . . . Tang T.
(2014). Therapeutic potentials of gene silencing by RNA interference:
principles, challenges, and new strategies. Gene , 538 ,
217-227.
Dutta D., & Donaldson J. G. (2012). Search for inhibitors of
endocytosis: Intended specificity and unintended consequences.Cell Logist , 2 , 203-208.
Elbashir S. M., Harborth J., Lendeckel W., Yalcin A., Weber K., &
Tuschl T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA
interference in cultured mammalian cells. Nature , 411 ,
494-498.
Hsu T., & Mitragotri S. (2011). Delivery of siRNA and other
macromolecules into skin and cells using a peptide enhancer.Proceedings of the National Academy of Sciences of the United
States of America , 108 , 15816-15821.
Jones S. W., Christison R., Bundell K., Voyce C. J., Brockbank S. M.,
Newham P., & Lindsay M. A. (2005). Characterisation of cell-penetrating
peptide-mediated peptide delivery. Br J Pharmacol , 145 ,
1093-1102.
Kim S. W., Kim N. Y., Choi Y. B., Park S. H., Yang J. M., & Shin S.
(2010). RNA interference in vitro and in vivo using an arginine
peptide/siRNA complex system. Journal of Controlled Release ,143 , 335-343.
Kim T. H., Ihm J. E., Choi Y. J., Nah J. W., & Cho C. S. (2003).
Efficient gene delivery by urocanic acid-modified chitosan. J
Control Release , 93 , 389-402.
Koren E., & Torchilin V. P. (2012). Cell-penetrating peptides: breaking
through to the other side. Trends in Molecular Medicine ,18 , 385-393.
Langlet-Bertin B., Leborgne C., Scherman D., Bechinger B., Mason A. J.,
& Kichler A. (2010). Design and Evaluation of Histidine-Rich
Amphipathic Peptides for siRNA Delivery. Pharmaceutical Research ,27 , 1426-1436.
Lee S. J., Son S., Yhee J. Y., Choi K., Kwon I. C., Kim S. H., & Kim K.
(2013). Structural modification of siRNA for efficient gene silencing.Biotechnol Adv , 31 , 491-503.
Levine R. M., Scott C. M., & Kokkoli E. (2013). Peptide functionalized
nanoparticles for nonviral gene delivery. Soft Matter , 9 ,
985-1004.
Mitchell D. J., Kim D. T., Steinman L., Fathman C. G., & Rothbard J. B.
(2000). Polyarginine enters cells more efficiently than other
polycationic homopolymers. J Pept Res , 56 , 318-325.
Pathak A., Patnaik S., & Gupta K. C. (2009). Recent trends in non-viral
vector-mediated gene delivery. Biotechnol J , 4 , 1559-1572.
Sarett S. M., Nelson C. E., & Duvall C. L. (2015). Technologies for
controlled, local delivery of siRNA. J Control Release ,218 , 94-113.
Sarett S. M., Werfel T. A., Chandra I., Jackson M. A., Kavanaugh T. E.,
Hattaway M. E., . . . Duvall C. L. (2016). Hydrophobic interactions
between polymeric carrier and palmitic acid-conjugated siRNA improve
PEGylated polyplex stability and enhance in vivo pharmacokinetics and
tumor gene silencing. Biomaterials , 97 , 122-132.
Schmidt N., Mishra A., Lai G. H., & Wong G. C. (2010). Arginine-rich
cell-penetrating peptides. FEBS Lett , 584 , 1806-1813.
Schneider C. A., Rasband W. S., & Eliceiri K. W. (2012). NIH Image to
ImageJ: 25 years of image analysis. Nature Methods , 9 ,
671-675.
Sinn P. L., Sauter S. L., & McCray P. B., Jr. (2005). Gene therapy
progress and prospects: development of improved lentiviral and
retroviral vectors–design, biosafety, and production. Gene
Therapy , 12 , 1089-1098.
Tai W., & Gao X. (2017). Functional peptides for siRNA delivery.Advanced Drug Delivery Reviews , 110-111 , 157-168.
Tang H. Y., Yin L. C., Kim K. H., & Cheng J. J. (2013). Helical
poly(arginine) mimics with superior cell-penetrating and molecular
transporting properties. Chemical Science , 4 , 3839-3844.
Vives E., Brodin P., & Lebleu B. (1997). A truncated HIV-1 Tat protein
basic domain rapidly translocates through the plasma membrane and
accumulates in the cell nucleus. J Biol Chem , 272 ,
16010-16017.
Wang H., Chen W., Xie H., Wei X., Yin S., Zhou L., . . . Zheng S.
(2014). Biocompatible, chimeric peptide-condensed supramolecular
nanoparticles for tumor cell-specific siRNA delivery and gene silencing.Chemical Communications , 50 , 7806-7809.
Wang J., Lu Z., Wientjes M. G., & Au J. L. (2010). Delivery of siRNA
therapeutics: barriers and carriers. AAPS J , 12 , 492-503.
Wang Y.-H., Hou Y.-W., & Lee H.-J. (2007). An intracellular delivery
method for siRNA by an arginine-rich peptide. Journal of
Biochemical and Biophysical Methods , 70 , 579-586.
Whitehead K. A., Langer R., & Anderson D. G. (2009). Knocking down
barriers: advances in siRNA delivery. Nat Rev Drug Discov ,8 , 129-138.
Yin H., Kanasty R. L., Eltoukhy A. A., Vegas A. J., Dorkin J. R., &
Anderson D. G. (2014). Non-viral vectors for gene-based therapy.Nat Rev Genet , 15 , 541-555.
Zeller S., Choi C. S., Uchil P. D., Ban H. S., Siefert A., Fahmy T. M.,
. . . Kumar P. (2015). Attachment of Cell-Binding Ligands to
Arginine-Rich Cell-Penetrating Peptides Enables Cytosolic Translocation
of Complexed siRNA. Chemistry & Biology , 22 , 50-62.
Zhou Z., Liu X., Zhu D., Wang Y., Zhang Z., Zhou X., . . . Shen Y.
(2017). Nonviral cancer gene therapy: Delivery cascade and vector
nanoproperty integration. Adv Drug Deliv Rev , 115 ,
115-154.